Zoetis Gets USDA Approval for Cytopoint Plus to Treat Allergic Dermatitis in Dogs

PUBT · 2d ago
Zoetis Gets USDA Approval for Cytopoint Plus to Treat Allergic Dermatitis in Dogs
  • Zoetis received USDA licensure for Cytopoint Plus to treat allergic dermatitis in dogs.
  • The monoclonal antibody provides 75 days of allergic itch relief per injection, the longest treatment interval among licensed therapies of its kind.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zoetis Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202611110730BIZWIRE_USPR_____20261111_BW108155) on November 11, 2026, and is solely responsible for the information contained therein.